Google Ads for mass tort and pharmaceutical litigation firms: the build order

Healthcare is not one advertising problem, it is three stacked. Is the treatment advertisable at all? Does the advertiser need certification first? And can the result be measured without disclosing protected health information? A vertical can pass two of those and be stopped dead by the third, and the order matters — there is no point building a keyword list for a category that cannot run.

Google does not sign a business associate agreement for Google Ads. So when a standard tag fires on a page named for a condition, the request that leaves the browser carries an identifier and a URL that names what the visitor was reading — a disclosure of protected health information to a third party. The remarketing tag builds those audience lists automatically, whether or not anyone ever targets them, and that association is the problem. For mass tort and pharmaceutical litigation firms this is not theoretical: the page structure that is good for search is exactly the structure that creates it.

This is the step we get called about most. If you do not have a developer for it, that is the normal situation rather than the exception — it is most of what we do, and it is worth fixing before the spend rather than after.

For mass tort and pharmaceutical litigation firms the conversion that matters is a claimant retained after criteria review, and it lives in your intake and case management system — not in the ad platform. Google can only optimize toward what you send it, so whatever you pick here decides what the algorithm spends the next ninety days chasing.

The conversion is a retained claimant after medical record and criteria review. is easy to generate and expensive to hold. Optimize toward it and the account gets very good at finding people who will book and not arrive, or arrive and not proceed — and it will report that as an improving cost per conversion the whole time. The stage that pays is a claimant retained after criteria review, and it sits below the line the ad platform can see.

Google enables these on every new Search campaign, and none of them are keyword decisions. Everything else in this playbook operates on whatever is left after they have taken their cut.

For Mass tort · Restrict each tort campaign to states where the statute of limitations and your referral agreements allow a case, and keep ads running around the clock in the first weeks after a recall or verdict.

One flat keyword list is why most practices cannot tell which half of the budget works. Sorting by the intent behind the search lets you bid, write and judge each group on its own terms — and in health it also separates the problem-aware searches, whose landing pages are the ones carrying your privacy exposure.

Every health vertical has searches that look commercial and are not: job seekers, students, people looking for free care, and researchers who will never book. Broad and phrase match will find all of them for you. Add this at the account level on day zero.

Exact match includes close variants — misspellings, plurals, reordered words, dropped function words. Phrase now behaves roughly like the old broad-match-modified. Broad reaches as far as Google judges useful, which with a trustworthy conversion signal is valuable and without one is an open tap. Start narrow, prove the signal, then widen.

For Mass tort · Phrase and exact on product-plus-lawsuit terms. Broad match on a product name reaches side-effect, dosage and news readers who never meet criteria.

Ad groups exist so the ad can answer the search. The moment a group holds two intents the ad has to be vague enough to cover both, and vague ads lose on relevance before budget enters the picture.

Health is where misrepresentation enforcement is heaviest. Outcome promises, guarantee language and before-and-after implications are the standard disapproval causes, and a pattern of them reads as circumvention rather than a mistake. Every line below is written to be provable on arrival. Character counts are shown because assets over the limit are rejected at upload.

Published cost-per-click figures for health verticals differ by an order of magnitude between sources, so a benchmark from an article is worse than useless. Work backwards from four numbers you already have. The floor is whatever buys roughly thirty conversions a month — below that, smart bidding never leaves the learning phase and you are paying auction prices for a sample too small to teach you anything.

For Mass tort · Retained claimants trail clicks by weeks of criteria review and record requests, so a week shows screened intakes at best. Fund the first tort enough to collect a meaningful batch of screened intakes before judging.

Position is not bought, it is earned and then paid for. Google ranks you on your bid multiplied by how good it expects your ad and landing page to be — so a relevant advertiser at half the bid outranks a vague one, and then pays less per click at the same position.

For Mass tort · Lead aggregators and national TV firms set the price, and it climbs as competitors pile in after a verdict or MDL formation. Being live before that flood matters more than outbidding it later.

Maximize Conversions on retained claimants. Raw leads are cheap, plentiful and mostly ineligible. Smart bidding is a data problem before it is a strategy problem: with thin or wrong conversion data it will confidently optimize toward noise, and it does that faster than a manual account can lose money.

For Mass tort · Start on Maximize Conversions toward intakes that pass the criteria screen, then switch to retained claimants with case values once enough retainers import. Bidding on raw leads trains Google toward fraud and duplicates.

Most accounts are killed or rescued on evidence that could not have meant anything yet. Health cycles are longer than most — a consultation booked in week three may not become revenue until week ten — so the honest schedule is longer too.

For Mass tort · Watch retention rate by search term first, not cost per lead, and log every disqualification reason. A tort whose retained rate stays near zero after a month needs new terms or a pause.

An account left alone drifts toward the cheapest clicks it can find, because that is what the system does when nobody corrects it. This is the shortest routine that keeps it honest.

For Mass tort · Negate settlement-status, payout-date and news queries each week, and check intake for claimants already signed elsewhere or outside the date range, mapping each one to the keyword that sent it.